Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Plos One|April 25, 2018
FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosisArvind Ponnusamy, Smeeta Sinha, Gareth D Hyde, et al.Clinical Kidney Journal|December 10, 2025
Calciphylaxis diagnosis, management and future directions: a comprehensive update on behalf of the European Renal Association CKD-MBD Working GroupSharon Huish, Sacha Moore, Carlo Alfieri, et al.Nephron|December 22, 2021
A Quality Improvement Project to Minimize COVID-19 Infections in Patients Receiving Haemodialysis and the Role of Routine Surveillance Using Nose and Throat Swabs for SARS-CoV-2 rRT-PCR and Serum Antibody TestingDimitrios Poulikakos, Rajkumar Chinnadurai, Yvonne Mcgee, et al.Cardiovascular Research|October 15, 2008
Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cellsMasih-ul Alam, John Paul Kirton, Fiona L Wilkinson, et al.Advances in Therapy|September 23, 2025
A Strategic Roadmap to Support Communication on and Acceptance of Surrogate Endpoints: The REnal Surrogacy accEpTance in Chronic Kidney Disease (RESET CKD) CollaborationJuan José Garcia Sanchez, Marta Trapero-Bertran, Oriana Ciani, et al.Kidney International|January 26, 2025
Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceMarkus Ketteler, Pieter Evenepoel, Rachel M Holden, et al.Clinical Kidney Journal|January 17, 2022
The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxisSmeeta Sinha, Lisa J Gould, Sagar U Nigwekar, et al.Eclinicalmedicine|September 10, 2024
Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extensionSmeeta Sinha, Sagar U Nigwekar, Vincent Brandenburg, et al.BMC Nephrology|December 8, 2020
Safely reducing haemodialysis frequency during the COVID-19 pandemicMichelle Da Silva Lodge, Thilini Abeygunaratne, Helen Alderson, et al.Kidney International|October 1, 2025
Changing paradigms of studies in kidney diseasesAdeera Levin, Allison Jaure, Dustin J Little, et al.Pageof 10